Home > Blog Tag

Blog Posts by Tag: Laboratory

Don’t Let a Crisis Misguide Your Choice in Revenue Cycle Management Systems for Outreach or Outpatient Labs

Hospital outreach program leaders are very familiar with management from the hospital or health system proposing that the current electronic health record (EHR) system is sufficient to support the outreach and outpatient laboratory revenue cycle management (RCM) process. “It’ll save money,” they say. “They (the vendor) tell us that it works fine for outreach and outpatient lab claims,” they add....

Read


CMS Has Largest-Ever Public Meeting – Discusses Pricing Lab Test Codes

On June 22, 2020, CMS held its largest-ever annual public meeting for pricing new laboratory test codes. In addition, it was the first-ever meeting held only virtually. Nearly 30 different organizations offered comments on some 130 new codes. A full transcript of the meeting is available at the blog “Discoveries in Health Policy.” The blog’s author, Bruce Quinn MD PhD, told XIFIN...

Read


The Two Most Important Documents Produced by a Lab: Results and Claims

In today’s complex diagnostics market, it is easy for lab leaders to get distracted by rapid volume changes, new regulations, fee schedule changes, restrictive payor policies, and significant reductions in reimbursements. The diagnostic providers that thrive in this often-unpredictable market are those that focus on the two most important information sources produced by a laboratory ― test...

Read


COVID-19 Puts a Spotlight on Billing DIY versus Outsourcing

As the economy starts to reopen and elective healthcare activities increase, hospital ancillary services, outreach programs, pathology practices, IDTF/remote patient monitoring companies, and independent labs must be ready to handle the volume surge. XIFIN’s Lab Volume Index data indicates a steady upward trend in lab volume; routine testing has already rebounded to nearly 80% of pre-COVID levels...

Read


How Laboratories Can Prepare for Coronavirus Coding and Billing Issues

Enjoy the following content from our partner, Infinx. However you feel about the current response to COVID-19, few people ever really expected to be here. We hold emergency preparedness drills and assign “essential personnel” status, but the scope of what we face seems too inconceivable. So now, we must balance providing the care and testing the community needs with collecting the...

Read


Routine Lab Volume in the US Sees Steep Drop, Gradual Recovery Due to COVID-19

Diagnostic laboratories remain at the forefront of US efforts to assess and control the spread of COVID-19. Diagnostics play a critical role both in the US pandemic response and also in helping the country as states establish plans to re-open. As states, and therefore laboratories, continue to focus on COVID-19 virus testing with the recent addition of antibody testing, elective and non-urgent...

Read


Pathology Volumes: Where’s the Surge?

As the laboratory market continues to feel the impact of COVID-19, one of the most hard-hit types of labs from both a decline in testing volume and revenue is pathology practices. At the beginning of the pandemic, many pathology labs immediately experienced a decline in testing volume. Based on XIFIN client data, at the lowest point, pathology volume was down 46% the week of April 13,...

Read


XIFIN LIS Helps Customers Rapidly Respond to COVID-19 Testing Needs

Conor WardVP of Sales, XIFIN Joe NollarAVP LIS Product Development, XIFIN Very shortly after the COVID-19 pandemic reached the US and states began instituting “stay at home” orders, routine lab testing volume dramatically dropped off. At its lowest point, based on XIFIN client data, average...

Read